• Ceacareanu A.C., Nimako G.K., Wintrob Z.A. Missing the benefit of metformin in AML: a problem of contrast?”. (2017) J. Res Pharm Practice. Jul-Sep;6(3):145-150
  • Wintrob Z.A.P., Hammel J.P., Nimako G.K., Zahra S. Fayazi, Gaile D.P., Forrest A., Ceacareanu A.C. (2017) “Insulin secretagogues use and circulating inflammatory C-C chemokine levels in breast cancer patients”. Data in Brief. Feb 16; 11:391-402
  • Wintrob Z.A.P., Hammel J.P., Nimako G.K., Gaile D.P., Forrest A., Ceacareanu A.C. (2017) “Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer”. Data in Brief. Feb 20;11:277-283
  • Wintrob Z.A.P., Hammel J.P., Nimako G.K., Gaile D.P., Forrest A., Ceacareanu A.C. (2017) “TH1 and Th2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer”. Data in Brief. Feb 20;11:331-348
  • Wintrob Z.A.P., Hammel J.P., Nimako G.K., Gaile D.P., Forrest A., Ceacareanu A.C. (2017) “Circulating growth factor data associated with insulin secretagogue use in women incident breast cancer”. Data in Brief. Feb 22;11:459-468
  • Wintrob Z.A.P., Hammel J.P., Nimako G.K., Gaile D.P., Forrest A., Ceacareanu A.C. (2017) “Insulin use, hormone receptor status and hematopoietic cytokines’ circulation in women with diabetes mellitus and cancer”. Data in Brief. Feb 21;11:382-390
  • Wintrob Z.A.P., Hammel J.P., Nimako G.K., Zahra S. Fayazi, Gaile D.P., Davis E.E. Forrest A., Ceacareanu A.C. (2017) “Data report on inflammatory C-C chemokines among insulin-using women with diabetes mellitus and cancer”. Data in Brief. Feb 22;11:446-458
  • Wintrob Z.A.P., Hammel J.P., Nimako G.K., Gaile D.P., Forrest A., Ceacareanu A.C. (2017) “TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer”. Data in Brief. Feb 22; 11: 413-427
  • Wintrob Z.A.P., Hammel J.P., Nimako G.K., Gaile D.P., Forrest A., Ceacareanu A.C. (2017). “Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer”. Data in Brief. Feb 13; 11:183-191
  • Wintrob Z.A.P., Hammel J.P., Khoury T., Nimako G.K., Fu H-W., Fayazi Z.S., Gaile D.P., Forrest A., Ceacareanu A.C. (2017) “Insulin use, adipokine profiles and breast cancer prognosis”. Cytokine. 89:45-61
  • Wintrob Z.A.P., Hammel J.P., Nimako G.K., Fayazi Z.S., Gaile D.P., Forrest A., Ceacareanu A.C. (2016) “Circulating adipokines data associated with insulin secretagogue use in breast cancer patients”. Data in Brief. Nov 22;10:238-247
  • Nimako G.K., Wintrob Z.A.P., Sulik D.A., Donato J.L., Ceacareanu A.C. “Synergistic benefit of statin ad metformin in gastrointestinal malignancies” (2016). J Pharm Pract. Jan 25:1-10
  • Ceacareanu A.C. and Wintrob Z.A.P. (2015). “Pharmacokinetic considerations in oncology”. In Cohen H., Casebook in clinical pharmacokinetics and drug dosing (pp. 261-276). United States, Mc-Graw-Hill Press. ISBN 9780071628358. NLM ID 101644598;
  • Ceacareanu A.C. “A pharmacist perspective on metformin use and cancer outcomes” (2015). J Pharm Pract. 28(1): 44-45
  • Wintrob Z.A.P., Oppong E.K., Foster M., Martorana M., Tse Y.C., Zhong L., Welt J.M., Boateng H.R., Drumea I.M., Irlam J., LeVea C.M., Faitar S.L., Ceacareanu A.C. (2014) “Sexual dimorphism, weight gain and glucose intolerance in a B- and T-cell deficient mouse model”. Cytokine. 67(2):102-6
  • Rabey J.L., Yin J., Kublas T.M., Mashtare T., Ceacareanu A.C. (2014) “Management of comorbidities in diabetics with renal cell carcinoma: past utilization and current outcomes”. J Pharm Pract. 27(1):31-9
  • Hong C-C., Shah A.B., Jackowiack C.M., Fu H-W., Nimako G.K., Kossoff E., Kubblas T.M., Edge S.B., Ceacareanu A.C. (2013) “Cholesterol drugs improve breast cancer prognosis in women with diabetes mellitus”. Adv in Pharmacoepidem Drug Safety 130 (2) doi: 10.4172/2167-1052.1000130
  • Ceacareanu A.C. (2012) “Is there a role for statins in the development of diabetes mellitus?” Arch Int Med.  http://archinte.jamanetwork.com/article.aspx?articleid=1108676
  • Zou J., Jafr G., Themistou E., Yap Y., Alexandridis P, Wintrob Z.A.P., Ceacareanu A.C., Cheng C. (2011) “PH-Sensitive Brush Polymer-Drug Conjugates by Ring-Opening Metathesis Copolymerization”. Chem Commun (Camb). 47(15):4493-5
  • Chang Y., Ceacareanu B., Zhuang D., Zhang C., Pu Q., Ceacareanu A.C., Hassid A. (2006) “Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation”. Arterioscler Thromb Vasc Biol. 26(3):501-7.
  • Ceacareanu A.C., Ceacareanu B., Zhuang D., Chang Y., Ray R.M., Desai L., Chapman K.E., Waters C.M., Hassid A. (2006) “Nitric oxide attenuates IGF-I-induced aortic smooth muscle cell motility by decreasing Rac1 activity: essential role of PTP-PEST and p130cas”. Am J Physiol Cell Physiol. 290(4):C1263-70
  • Zhuang D., Ceacareanu A.C., Ceacareanu B., Hassid A. (2005) “Essential role of protein kinase G and decreased cytoplasmic Ca2+ levels in NO-induced inhibition of rat aortic smooth muscle cell motility”. Am J Physiol Heart Circ Physiol. 288(4):H1859-66
  • Ceacareanu A.C., Ceacareanu B., Ofiteru A., Rodewald A., Szegli G. (2004) “Distribution of D1S80 alleles and their Tsp509I subtypes in Romanian population”. Journal of Forensic Sciences 49(4):865
  • Zhuang D., Ceacareanu A.C., Lin Y., Ceacareanu B, Dixit M., Chapman K., Waters C.M., Rao G.N., Hassid A. (2004) “Nitric oxide attenuates insulin- or IGF1-stimulated aortic smooth muscle cell motility by hydrogen peroxide: Essential role of cyclic GMP”. Am J Physiol Heart Circ Physiol. 286(6):H2103-12
  • Lin Y., Ceacareanu A.C., Hassid A. (2003) “NO induced inhibition of aortic smooth muscle cell motility: role of protein tyrosine phosphatase-PEST and adapter proteins p130cas and CRK “.Am J Physiol Heart Circ Physiol. 285(2):H710-21
  • Sidorovitch V., Niculae A., Kan N., Ceacareanu A.C., Alexandrov K. (2002) “Expression of mammalian Rab Escort Protein -1 and -2 in yeast Saccharomyces cerevisiae”. Protein expression and purification, 26 (1):50-8
  • Dursina B., Thomä N.H., Sidorovitch V., Niculae A., Iakovenko A., Rak A, Albert S., Ceacareanu A.C., Herrmann C., Goody R.S., Alexandrov K. (2002) “Interaction of yeast Rab geranylgernyl transferase with its protein and lipid substrates”. Biochemistry 41(21):6805-16
  • Ceacareanu A.C., Ceacareanu B. (1999) “RAPD markers, indeed a possibility for human identification?” Revue of National Society for Cellular Biology 27 (Jun), 111-112
  • Ceacareanu A.C., Ceacareanu B. (1999) “The relevance of paternity analysis in Romanian population using the D1S80 locus”. Rom. Arch. Imm. Microb. vol. 58(3-4):281-9
  • Ceacareanu A.C., Ceacareanu B., Ofiteru A., Szegli G. (1999) “Parentage analysis for three Romanian families”. Rom. Arch. Imm. Microb. 58(2):197-202
  • Onu A., Ceacareanu A.C., Szegli G. (1998) “Chimerical constructs of IL15 aimed to analyze the pathways of its production”. Rev. Roum. Biochim. 35(1-2):146-7
Advertisements